Abstract
The development of leukemia in donor cells after allogeneic hematopoietic stem cell transplant is an extremely rare event. We report here the case of a patient who developed myelodysplastic syndrome/acute myeloid leukemia, in cells of donor origin 3.5 years after related donor HSCT for refractory chronic lymphocytic leukemia and therapy-induced myelodysplastic syndrome. The origin of the leukemia was determined by analysis of minisatillite polymorphism tested on CD34+ cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Leone G, Mele L, Pulsoni A et al. The incidence of secondary leukemias Haematologica 1999 84: 937 945
Kantarjian HM, Keating MJ, Walters RS et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features J Clin Oncol 1986 4: 1748 1757
Heim S . Cytogenetic findings in primary and secondary MDS Leuk Res 1992 16: 43 46
Larson RA, LeBeau MM, Vardiman JW, Rowley JD . Myeloid leukemia after hematotoxins Environ Health Perspect 1996 104: (Suppl. 6) 1303 1307
Deeg HJ, Appelbaum FR . Hemopoietic stem cell transplantation for myelodysplastic syndrome Curr Opin Oncol 2000 12: 116 120
Arnold R, de Witte T, van Biezen A et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group Bone Marrow Transplant 1998 21: 1213 1216
Witherspoon RP, Deeg HJ . Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia Haematologica 1999 84: 1085 1087
Nevill TJ, Shepherd JD, Brockington DA et al. Outcome analysis and risk factors predictive of survival in stem cell transplantation (SCT) for therapy-induced myelodysplastic syndrome/acute myelogenous leukemia (tMDS/AML) Blood 2001 98: 625a (Abstr.)
Fialkow PJ, Thomas ED, Bryant JI, Neiman PE . Leukaemic transformation of engrafted human marrow cells in vivo Lancet 1971 i: 251 255
Blazar BR, Orr HT, Arthur DC et al. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation Blood 1985 66: 1436 1444
Budowle B, Chakraborty R, Giusti AM et al. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE Am J Hum Genet 1991 48: 137 144
McCann SR, Lawler M, Humphries P et al. Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies Blood 1992 79: 2803 2805
Mitelman F . ISCN (1995) An International System for Human Cytogenetic Nomenclature Karger: Basel 1995 1995
Pedersen-Bjergaard J, Andersen MK, Christiansen DH . Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation Blood 2000 95: 3273 3279
Krishnan A, Bhatia S, Slovak ML et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors Blood 2000 95: 1588 1593
Milligan DW, Ruiz De Elvira MC, Kolb HJ et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation Br J Haematol 1999 106: 1020 1026
Van Den Neste E, Louviaux I, Michaux JL et al. Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2′-deoxyadenosine Br J Haematol 1999 105: 268 270
Thomas ED, Buckner CD, Fefer A et al. Leukaemic transformation of engrafted human marrow cells in vivo Lancet 1972 i: 1310 1313
Schmitz N, Johannson W, Schmidt G et al. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6 Blood 1987 70: 1099 1104
Cooley LD, Sears DA, Udden MM et al. Donor cell leukemia: report of a case occuring 11 years after allogeneic bone marrow transplantation and review of the literature Am J Hematol 2000 63: 46 53
Witherspoon RP, Schubach W, Neiman PE et al. Donor cell leukemia developing six years after marrow grafting for acute leukemia Blood 1985 65: 1172 1174
Mielcarek M, Bryant E, Loken M et al. Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation Br J Haematol 1999 105: 361 365
Niederwieser DW, Appelbaun FR, Gastl G et al. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia New Engl J Med 1990 322: 1794 1796
Duhrsen U, Hossfeld DK . Stromal abnormalities in neoplastic bone marrow diseases Ann Hematol 1996 73: 53 70
McCann SR, Lawler M, Bacigalupo A . Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia Leuk Lymphoma 1993 10: 419 425
Simmons PJ, Przepiorka D, Thomas ED et al. Host origin of marrow stromal cells following allogeneic bone marrow transplantation Nature 1987 328: 429 432
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brunstein, C., Hirsch, B., Hammerschmidt, D. et al. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 29, 999–1003 (2002). https://doi.org/10.1038/sj.bmt.1703577
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703577
Keywords
This article is cited by
-
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
Bone Marrow Transplantation (2021)
-
Donor-derived isolated del(20q) after hematopoietic stem cell transplantation: report of two cases and review of the literature
Journal of Hematopathology (2013)
-
Donor-cell MDS in a 12-year-old girl 3 years after allogeneic hematopoietic SCT for MDS, both with a t(3;3)(q21;q26) cytogenetic aberration
Bone Marrow Transplantation (2011)
-
Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making
International Journal of Hematology (2011)
-
Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation
Stem Cell Reviews and Reports (2010)